Liberty Health Resumes Florida Medical Cannabis Operations After Hurricane Irma

Liberty Health Sciences Inc. Confirms No Structural Damage to Florida Facility Following Hurricane Irma


Liberty contributing 10 per cent of revenues to Red Cross; Expansion plans still on track

TORONTO, Sept. 11, 2017 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCBB: SCQBF) (“Liberty” or the “Company”) announced today that there is no structural damage to its facility in Alachua, Florida as a result of Hurricane Irma. In addition, no part of Liberty’s production process was affected, nor were any plants or inventories damaged because of the storm. All business operations have resumed with the exception of deliveries to our patients, which will recommence as soon as it is safe to do so.

Our hearts go out to all those affected by the devastation caused by Hurricane Irma and we are committed to providing support to ensure that local residents, including our employees, stay safe. Also, Liberty is proud to be a positive force in the community and to help with the relief efforts across the State of Florida, we are committing to contributing 10 per cent of revenues for two months to support the incredible relief efforts being undertaken by the Red Cross.

George Scorsis, CEO and Director of Liberty

A tropical storm warning remains in effect for Alachua, Florida for the next 24 hours and Liberty will provide further updates as events warrant.

Despite the storm, Liberty’s previously announced Part II expansion plans for the Alachua facility remain on track. This expansion will increase Liberty’s annual medical cannabis production to 2,800kgs by January 2018.

For more information on Liberty please visit

About Liberty Health Sciences Inc.

Liberty Health Sciences Inc. (“Liberty”) is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in U.S. states where medical cannabis is legal. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.

Original press release:


Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter